Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
START Center for Cancer Care
San Antonio, Texas, United States
- Ownership
- Private
- Employees
- ~266
- Development stage
- Other
01
Overview
START operates the world’s largest community-based Phase I clinical trials program in oncology and has participated in the development of over 45 FDA/EMA-approved therapies. The organization routinely publishes and presents key clinical research results and provides early access to innovative therapies for cancer patients.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyBispecific monoclonal antibodyImmunotherapyChemotherapyRadiation therapyCell therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
Nektar TherapeuticsZymeworks
Beyond the preview
Go deeper on START Center for Cancer Care.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on START Center for Cancer Care.